Table 3.

Univariate and multivariate analysis of prostate cancer specific survival.

	Univariate		Multivariate
	HR (95 CI)	P	HR (95 CI)	P
Age (yr)
65–74	1.0	–	1.0	–
35–44	1.02 (0.14–7.40)	0.98	3.39 (0.44–25.78)	0.24
45–54	0.66 (0.38–1.15)	0.14	0.58 (0.20–1.68)	0.31
55–64	0.62 (0.45–0.94)	<0.05	1.04 (0.60–1.78)	0.90
Gleason score
6	1.0	–	1.0	–
7	1.72 (0.88–3.34)	0.11	0.99 (0.40–2.46)	0.99
8–10	20.56 (11.09–38.11)	<0.05	7.76 (3.19–18.90)	<0.05
Unknown	2.93 (1.44–5.94)	<0.05	1.36 (0.49–3.79)	0.55
Stage
T1/T2	1.0	–	1.0	–
T3/T4	10.39 (6.76–15.96)	<0.05	5.45 (2.94–10.10)	<0.05
PSA	0.99 (0.9–1.04)	0.73	0.99 (0.94–1.05)	0.82
Location
Metropolitan	1.0	–	1.0	–
Rural	0.94 (0.64–1.39)	–	0.74	0.37

CI, confidence interval; HR, hazard ratio; PSA, prostate-specific antigen.